1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. FDA Discusses Registration and Listing Rules for LDTs

FDA Discusses Registration and Listing Rules for LDTs

Dec 10, 2024

On December 3, the FDA led a webinar reviewing compliance for its registration and device listing requirements for laboratory-developed tests (LDTs). These requirements are part of stage 2 of the FDA LDT oversight regulation and take effect May 2026. Stage 1 requirements take effect May 6, 2025.

The CAP had previously urged the FDA to provide more education about the agency’s process for registration and listing how the process would apply to LDTs.

Review the FDA webinar slides and webpage.

Most Recent Content

  1. July 1, 2025
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  2. What’s in the Senate's "One Big Beautiful Bill"
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  3. CMS eases lab personnel rules with new guidance
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  4. Lab groups: Bring back CLIAC
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  5. Supreme Court backs no-cost preventive care panel
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  6. View All
To Top